Julia Eden
Family · Mount Vernon, MONPI 1821733833
Payments from drug & device makers
Across 144 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$372
- AstraZeneca$344
- Lilly USA, LLC$321
- Novo Nordisk$309
- Otsuka America Pharmaceutical, Inc.$230
- Vanda Pharmaceuticals Inc.$200
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,878100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $372 |
| AstraZeneca | 15 | $344 |
| Lilly USA, LLC | 15 | $321 |
| Novo Nordisk | 24 | $309 |
| Otsuka America Pharmaceutical, Inc. | 7 | $230 |
| Vanda Pharmaceuticals Inc. | 9 | $200 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $200 |
| Neurocrine Biosciences, Inc. | 10 | $192 |
| Organon | 2 | $112 |
| Astellas Pharma US Inc | 1 | $107 |
| GSK | 5 | $71 |
| Nestle Healthcare Nutrition Inc. | 3 | $47 |
| Boehringer Ingelheim | 3 | $47 |
| Exact Sciences | 3 | $43 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| Dexcom, Inc. | 3 | $41 |
| Eisai Inc. | 1 | $34 |
| Mylan Specialty L.p. | 2 | $28 |
| Halozyme Inc | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Novartis | 1 | $17 |
| Amgen | 1 | $17 |
| Bayer | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,878 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 40 | $25,248 |
| TrulicityDulaglutide | 21 | $22,782 |
| JardianceEmpagliflozin | 23 | $18,482 |
| EliquisApixaban | 24 | $16,417 |
| OzempicSemaglutide | 15 | $16,188 |
| MounjaroTirzepatide | 11 | $16,151 |
| XareltoRivaroxaban | 11 | $10,620 |
| MyrbetriqMirabegron | 12 | $4,027 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $1,994 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $1,739 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $1,689 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $1,642 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,627 |
| Omeprazole | 59 | $499 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $488 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $321 | $38,93232 claims |
| AstraZenecaFarxiga | $344 | $25,24840 claims |
| Boehringer IngelheimJardiance | $47 | $18,48223 claims |
| Novo NordiskOzempic | $309 | $16,18815 claims |
| Johnson & JohnsonXarelto | $15 | $10,62011 claims |
| Astellas Pharma US IncMyrbetriq | $107 | $4,02712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.
Other family in Mount Vernon
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.